Диссертация (1145685), страница 23
Текст из файла (страница 23)
Jahn // Nucleic Acids Res.– 2005. – Т. 33 – № suppl 2 – W526–W531 p.51. Grunberg-Manago M. Messenger RNA stability and its role in control of gene expression inbacteria and phages / M. Grunberg-Manago // Annu. Rev. Genet. – 1999. – Т. 33 – 193–227 p.52. Gudjonsson J.E. Immunopathogenic mechanisms in psoriasis / J.
E. Gudjonsson, A. Johnston, H.Sigmundsdottir, H. Valdimarsson // Clin. Exp. Immunol. – 2004. – Т. 135 – № 1 – 1–8 p.53. Günther S. Molecular determinants of agonist and antagonist signaling through the IL-36 receptor /S. Günther, E. J. Sundberg // J. Immunol. Baltim. Md 1950 – 2014. – Т. 193 – № 2 – 921–930 p.13254. Hamon Y. Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassettetransporter, ABC1 / Y. Hamon, M.
F. Luciani, F. Becq, B. Verrier, A. Rubartelli, G. Chimini // Blood– 1997. – Т. 90 – № 8 – 2911–2915 p.55. Heidenreich R. Angiogenesis drives psoriasis pathogenesis / R. Heidenreich, M. Röcken, K.Ghoreschi // Int. J. Exp. Pathol. – 2009.
– Т. 90 – № 3 – 232–248 p.56. Henry C.M. Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36Family Cytokines / C. M. Henry, G. P. Sullivan, D. M. Clancy, I. S. Afonina, D. Kulms, S. J. Martin //Cell Rep. – 2016. – Т. 14 – № 4 – 708–722 p.57. Hoffman S.J. Expression of fully functional tetrameric human hemoglobin in Escherichia coli / S.J. Hoffman, D. L. Looker, J. M. Roehrich, P. E. Cozart, S.
L. Durfee, J. L. Tedesco, G. L. Stetler //Proc. Natl. Acad. Sci. U. S. A. – 1990. – Т. 87 – № 21 – 8521–8525 p.58. Hussain S. IL36RN mutations define a severe autoinflammatory phenotype of generalized pustularpsoriasis / S. Hussain, D. M. Berki, S.-E. Choon, A. D. Burden, M. H. Allen, J. I. Arostegui, A.Chaves, M.
Duckworth, A. D. Irvine, M. Mockenhaupt, A. A. Navarini, M. M. B. Seyger, P. SolerPalacin, C. Prins, L. Valeyrie-Allanore, M. A. Vicente, R. C. Trembath, C. H. Smith, J. N. Barker, F.Capon // J. Allergy Clin. Immunol. – 2015. – Т. 135 – № 4 – 1067–1070.e9 p.59.
Jiang Z. Interleukin-36γ induced by the TLR3-SLUG-VDR axis promotes wound healing viaREG3A / Z. Jiang, Y. Liu, C. Li, L. Chang, W. Wang, Z. Wang, X. Gao, B. Ryffel, Y. Wu, Y. Lai // J.Invest. Dermatol. – 2017.60. Jorgensen I. Programmed cell death as a defence against infection / I.
Jorgensen, M. Rayamajhi, E.A. Miao // Nat. Rev. Immunol. – 2017. – Т. 17 – № 3 – 151–164 p.61. Julien O. Caspases and their substrates / O. Julien, J. A. Wells // Cell Death Differ. – 2017. – Т. 24– № 8 – 1380–1389 p.62. Kanazawa N. Novel IL36RN mutation in a Japanese case of early onset generalized pustularpsoriasis / N. Kanazawa, T. Nakamura, N. Mikita, F. Furukawa // J. Dermatol. – 2013. – Т. 40 – № 9 –749–751 p.13363. Keermann M.
Transcriptional landscape of psoriasis identifies the involvement of IL36 andIL36RN / M. Keermann, S. Kõks, E. Reimann, E. Prans, K. Abram, K. Kingo // BMC Genomics –2015. – Т. 16 – 322 p.64. Kelly J.B. Current and future oral systemic therapies for psoriasis / J. B. Kelly, P. Foley, B. E.Strober // Dermatol. Clin. – 2015. – Т. 33 – № 1 – 91–109 p.65.
Kerwin B.A. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structureand degradation pathways / B. A. Kerwin // J. Pharm. Sci. – 2008. – Т. 97 – № 8 – 2924–2935 p.66. Kingsbury D.J. Safety, effectiveness, and pharmacokinetics of adalimumab in children withpolyarticular juvenile idiopathic arthritis aged 2 to 4 years / D. J. Kingsbury, B. Bader-Meunier, G.Patel, V. Arora, J. Kalabic, H. Kupper // Clin. Rheumatol.
– 2014. – Т. 33 – № 10 – 1433–1441 p.67. Klotsche J. Long-term safety of etanercept and adalimumab compared to methotrexate in patientswith juvenile idiopathic arthritis (JIA) / J. Klotsche, M. Niewerth, J.-P. Haas, H.-I. Huppertz, A. Zink,G. Horneff, K. Minden // Ann. Rheum. Dis. – 2016. – Т. 75 – № 5 – 855–861 p.68. Kovach M.A. IL-36γ is a crucial proximal component of protective type-1-mediated lung mucosalimmunity in Gram-positive and -negative bacterial pneumonia / M.
A. Kovach, B. Singer, G.Martinez-Colon, M. W. Newstead, X. Zeng, P. Mancuso, T. A. Moore, S. L. Kunkel, M. PetersGolden, B. B. Moore, T. J. Standiford // Mucosal Immunol. – 2017.69. Kovach M.A. IL-36γ is secreted in microparticles and exosomes by lung macrophages in responseto bacteria and bacterial components / M.
A. Kovach, B. H. Singer, M. W. Newstead, X. Zeng, T. A.Moore, E. S. White, S. L. Kunkel, M. Peters-Golden, T. J. Standiford // J. Leukoc. Biol. – 2016. – Т.100 – № 2 – 413–421 p.70. Kumar S. Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B bindsto the IL-18 receptor but does not induce IFN-gamma production / S. Kumar, C. R. Hanning, M. R.Brigham-Burke, D. J. Rieman, R. Lehr, S.
Khandekar, R. B. Kirkpatrick, G. F. Scott, J. C. Lee, F. J.Lynch, W. Gao, A. Gambotto, M. T. Lotze // Cytokine – 2002. – Т. 18 – № 2 – 61–71 p.71. Kumar S. Identification and initial characterization of four novel members of the interleukin-1family / S. Kumar, P. C. McDonnell, R. Lehr, L. Tierney, M. N. Tzimas, D. E. Griswold, E.
A.134Capper, R. Tal-Singer, G. I. Wells, M. L. Doyle, P. R. Young // J. Biol. Chem. – 2000. – Т. 275 – №14 – 10308–10314 p.72. Kurinna S. Autocrine and Paracrine Regulation of Keratinocyte Proliferation through a NovelNrf2-IL-36γ Pathway / S. Kurinna, S. Muzumdar, U. A. Köhler, T.
Kockmann, U. Auf dem Keller, M.Schäfer, S. Werner // J. Immunol. Baltim. Md 1950 – 2016. – Т. 196 – № 11 – 4663–4670 p.73. Langley R.G. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis GlobalAssessment, and Lattice System Physician’s Global Assessment / R.
G. Langley, C. N. Ellis // J. Am.Acad. Dermatol. – 2004. – Т. 51 – № 4 – 563–569 p.74. Lazarevic V. T-bet in disease / V. Lazarevic, L. H. Glimcher // Nat. Immunol. – 2011. – Т. 12 – №7 – 597–606 p.75. Levine D. Evaluation and management of psoriasis: an internist’s guide / D. Levine, A. Gottlieb //Med. Clin. North Am. – 2009. – Т. 93 – № 6 – 1291–1303 p.76.
Levitt M. A simplified representation of protein conformations for rapid simulation of proteinfolding / M. Levitt // J. Mol. Biol. – 1976. – Т. 104 – № 1 – 59–107 p.77. Li N. Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36γ induction inhuman epidermal keratinocytes / N. Li, K. Yamasaki, R. Saito, S. Fukushi-Takahashi, R. ShimadaOmori, M. Asano, S. Aiba // J. Immunol. Baltim.
Md 1950 – 2014. – Т. 193 – № 10 – 5140–5148 p.78. Li R. Increased βTrCP are associated with imiquimod-induced psoriasis-like skin inflammation inmice via NF-κB signaling pathway / R. Li, J. Wang, X. Wang, J. Zhou, M. Wang, H. Ma, S. Xiao //Gene – 2016.79. Lian L.-H. The double-stranded RNA analogue polyinosinic-polycytidylic acid induceskeratinocyte pyroptosis and release of IL-36γ / L.-H. Lian, K. A. Milora, K. K. Manupipatpong, L. E.Jensen // J. Invest. Dermatol.
– 2012. – Т. 132 – № 5 – 1346–1353 p.80. Liang J. Mutations in IL36RN are associated with geographic tongue / J. Liang, P. Huang, H. Li, J.Zhang, C. Ni, Y. Wang, J. Shen, C. Li, L. Kang, J. Chen, H. Zhang, Z. Wang, Z. Zhang, M. Li, Z. Yao// Hum. Genet. – 2017. – Т. 136 – № 2 – 241–252 p.13581. Liao Y.-D. Removal of N-terminal methionine from recombinant proteins by engineered E. colimethionine aminopeptidase / Y.-D. Liao, J.-C. Jeng, C.-F.
Wang, S.-C. Wang, S.-T. Chang // ProteinSci. Publ. Protein Soc. – 2004. – Т. 13 – № 7 – 1802–1810 p.82. Liu H.F. Recovery and purification process development for monoclonal antibody production / H.F. Liu, J. Ma, C. Winter, R. Bayer // mAbs – 2010. – Т. 2 – № 5 – 480–499 p.83. Liu S. Removal of endotoxin from recombinant protein preparations / S. Liu, R. Tobias, S.McClure, G. Styba, Q. Shi, G. Jackowski // Clin.
Biochem. – 1997. – Т. 30 – № 6 – 455–463 p.84. López-Ferrer A. The safety of ustekinumab for the treatment of psoriatic arthritis / A. LópezFerrer, A. Laiz, L. Puig // Expert Opin. Drug Saf. – 2017. – Т. 16 – № 6 – 733–742 p.85. Lovenberg T.W. Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL1R-rp2) / T. W. Lovenberg, P.
D. Crowe, C. Liu, D. T. Chalmers, X. J. Liu, C. Liaw, W. Clevenger, T.Oltersdorf, E. B. De Souza, R. A. Maki // J. Neuroimmunol. – 1996. – Т. 70 – № 2 – 113–122 p.86. Lowe A.J. Methods for chromatographic removal of endotoxin / A. J. Lowe, C. L. Bardliving, C.A. Batt // Methods Mol. Biol. Clifton NJ – 2012. – Т.
899 – 265–275 p.87. Machado S.H. Safety of tocilizumab in the treatment of juvenile idiopathic arthritis / S. H.Machado, R. M. Xavier // Expert Opin. Drug Saf. – 2017. – Т. 16 – № 4 – 493–500 p.88. Magne D. The new IL-1 family member IL-1F8 stimulates production of inflammatory mediatorsby synovial fibroblasts and articular chondrocytes / D.
Magne, G. Palmer, J. L. Barton, F. Mézin, D.Talabot-Ayer, S. Bas, T. Duffy, M. Noger, P.-A. Guerne, M. J. H. Nicklin, C. Gabay // Arthritis Res.Ther. – 2006. – Т. 8 – № 3 – R80 p.89. Makrides S.C. Strategies for achieving high-level expression of genes in Escherichia coli / S. C.Makrides // Microbiol.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
